Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
NCT07242664
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitis
Interventions
DRUG:
GZR-33
Sponsor
Gan and Lee Pharmaceuticals, USA